Martin Shkreli, 29
Founder, MSMB Capital
As an activist hedge fund manager specializing in healthcare stocks, torpedoed the proposed merger of Amag Pharmaceuticals and Allos Therapeutics by launching his own hostile bid. Antagonized Pfizer to remove former CEO William Steere from its board. His latest: founding a biotech focused on rare diseases.